State WI
Clinical Trials in Wisconsin
Recruiting clinical trials with at least one study location in Wisconsin. Data updated daily from ClinicalTrials.gov.
Top Conditions in Wisconsin
NCT06664619 Phase 3
Recruiting
A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of F...
Condition
Asthma
Enrollment
724 pts
Location
United States, Argentina, Bulgaria
Sponsor
Teva Branded Pharmaceutical Pr
NCT05174169 Phase 2, Phase 3
Recruiting
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Condition
Stage III Colon Cancer
Enrollment
1,912 pts
Location
United States, Canada, Puerto Rico
Sponsor
NRG Oncology
NCT05668741 Phase 1, Phase 2
Recruiting
A Phase 1/2 Study of VX-522 in Participants With Cystic Fibrosis (CF)
Condition
Cystic Fibrosis
Enrollment
39 pts
Location
United States, Australia, Belgium
Sponsor
Vertex Pharmaceuticals Incorpo
NCT04161066 Phase 1
Recruiting
Adjunctive Effects of Psilocybin and a Formulation of Buprenorphine
Condition
Opioid Use Disorder
Enrollment
10 pts
Location
United States
Sponsor
University of Wisconsin, Madis
NCT06067503 Phase 2
Recruiting
Biomarkers to Detect Endocrine Therapy Resistance
Condition
Metastatic Cancer
Enrollment
8 pts
Location
United States
Sponsor
University of Wisconsin, Madis
NCT07018700 Phase 3
Recruiting
A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preve...
Condition
Episodic Migraine
Enrollment
990 pts
Location
United States, Austria, Czechia
Sponsor
Merz Therapeutics GmbH
NCT04886531 Phase 2
Recruiting
Trial of Pre-operative Neratinib and Endocrine Therapy With Trastuzumab in ER-Po...
Condition
Breast Cancer
Enrollment
30 pts
Location
United States
Sponsor
Ruth O'Regan
NCT05642572 Phase 2
Recruiting
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer...
Condition
Recurrent Lung Non-Small Cell Carcinoma
Enrollment
66 pts
Location
United States
Sponsor
SWOG Cancer Research Network
NCT06788639 N/A
Recruiting
A Study of Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia/Small ...
Condition
Chronic Lymphocytic Leukemia (CLL)
Enrollment
300 pts
Location
United States
Sponsor
Juno Therapeutics, Inc., a Bri
NCT05966467 N/A
Recruiting
Registry of Patients With AQP4+ NMOSD Treated With Alexion C5 Inhibitor Therapie...
Condition
Neuromyelitis Optica Spectrum Disorder
Enrollment
122 pts
Location
United States, Argentina, Canada
Sponsor
Alexion Pharmaceuticals, Inc.
NCT07061964 Phase 2
Recruiting
Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Rem...
Condition
Muscle Invasive Bladder Urothelial Carcinoma
Enrollment
111 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT05164172 Phase 3
Recruiting
A Study With Eptinezumab in Children and Adolescents (6 to 17 Years) With Chroni...
Condition
Migraine
Enrollment
600 pts
Location
United States, Argentina, Canada
Sponsor
H. Lundbeck A/S
NCT04166409 Phase 3
Recruiting
A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients Wit...
Condition
Low Grade Astrocytoma
Enrollment
170 pts
Location
United States, Canada, Puerto Rico
Sponsor
National Cancer Institute (NCI
NCT06052072 N/A
Recruiting
Pulmonary Artery DenerVation Clinical Study Using the Gradient Denervation Syste...
Condition
Group 2 Pulmonary Hypertension
Enrollment
50 pts
Location
United States
Sponsor
Gradient Denervation Technolog
NCT06637644 N/A
Recruiting
Impella RP Flex with Smart Assist
Condition
Right Ventricular (RV) Dysfunction
Enrollment
200 pts
Location
United States
Sponsor
Abiomed Inc.
NCT05126277 Phase 3
Recruiting
Safety, Efficacy and Tolerability of Ianalumab Versus Placebo, Combination With ...
Condition
Lupus Nephritis
Enrollment
462 pts
Location
United States, Argentina, Brazil
Sponsor
Novartis Pharmaceuticals
NCT06486428 N/A
Recruiting
Small Cell Lung Cancer Community Engagement to Eliminate Research Discepancies
Condition
Small-cell Lung Cancer
Enrollment
30 pts
Location
United States
Sponsor
Addario Lung Cancer Medical In
NCT07213921 N/A
Recruiting
Dermabrasion in Mohs: Split-Scar Trial
Condition
Wound Heal
Enrollment
50 pts
Location
United States
Sponsor
University of Wisconsin, Madis
NCT05472909 N/A
Recruiting
Music Interventions During Wide-Awake Hand Surgery
Condition
Anxiety
Enrollment
170 pts
Location
United States
Sponsor
University of Wisconsin, Madis
NCT05466214 N/A
Recruiting
Systematic Efficacy Replication Study of Conjoint Behavioral Consultation in Ele...
Condition
Emotional Disturbances
Enrollment
720 pts
Location
United States
Sponsor
American Institutes for Resear
NCT06008093 Phase 3
Recruiting
A Study to Investigate the Efficacy of Durvalumab Plus Tremelimumab in Combinati...
Condition
Carcinoma, Non-Small-Cell Lung
Enrollment
280 pts
Location
United States
Sponsor
AstraZeneca
NCT06203600 Phase 2, Phase 3
Recruiting
Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophage...
Condition
Advanced Esophageal Adenocarcinoma
Enrollment
224 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT04752722 Phase 1, Phase 2
Recruiting
LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incom...
Condition
Superficial Bladder Cancer
Enrollment
350 pts
Location
United States, Australia, Canada
Sponsor
enGene, Inc.
NCT05917522 Phase 2
Recruiting
Assessment of Biomarker-Guided CNI Substitution In Kidney Transplantation
Condition
Kidney Transplant
Enrollment
800 pts
Location
United States
Sponsor
National Institute of Allergy
NCT05948566 Phase 2
Recruiting
Strategy for Improving Stroke Treatment Response
Condition
Ischemic Stroke
Enrollment
300 pts
Location
United States
Sponsor
Translational Sciences, Inc.